| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $317,754 | 1 | 100 |
| Heffernan Michael Thomas | director | 0 | $0 | 1 | $317,754 | $-317,754 |
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with idiopathic pulmonary fibrosis. Trevi Therapeutics also possesses a licensing agreement with Endo Pharmaceuticals Inc., granting it …
Over the last 12 months, insiders at Trevi Therapeutics, Inc. have bought $0 and sold $317,754 worth of Trevi Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Trevi Therapeutics, Inc. have bought $18.61M and sold $378,540 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,631,578 shares for transaction amount of $5M was made by NEA 16 GP, LLC () on 2022‑04‑11.
| 2026-09-15 | Sale | Heffernan Michael Thomas | director | 21,052 0.0149% | $15.09 | $317,754 | -9.84% | |
| 2025-03-25 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 2,631 0.0027% | $6.60 | $17,365 | +32.68% | |
| 2025-03-21 | Sale | GOOD JENNIFER L | President & CEO | 5,263 0.0055% | $6.58 | $34,625 | +31.45% | |
| 2025-03-10 | Sale | Simon Farrell | Chief Commercial Officer | 81,313 0.1012% | $6.75 | $548,878 | +31.47% | |
| 2024-09-09 | Sale | GOOD JENNIFER L | President & CEO | 1,840 0.0025% | $3.04 | $5,587 | +71.47% | |
| 2024-09-06 | Sale | GOOD JENNIFER L | President & CEO | 4,219 0.006% | $3.03 | $12,784 | +78.98% | |
| 2024-09-05 | Sale | GOOD JENNIFER L | President & CEO | 40,277 0.0557% | $3.11 | $125,310 | +62.58% | |
| 2024-09-04 | Sale | GOOD JENNIFER L | President & CEO | 10,981 0.0155% | $3.02 | $33,205 | +59.32% | |
| 2024-09-03 | Sale | GOOD JENNIFER L | President & CEO | 3,863 0.0054% | $3.02 | $11,677 | +54.71% | |
| 2024-08-27 | Sale | Meeker David P | director | 4,555 0.0063% | $2.93 | $13,353 | +55.15% | |
| 2024-08-19 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 16,496 0.0227% | $2.96 | $48,883 | +46.13% | |
| 2024-08-16 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 18,660 0.0268% | $2.76 | $51,440 | +55.60% | |
| 2024-08-15 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 12,745 0.0185% | $2.79 | $35,513 | +56.55% | |
| 2024-08-14 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 100 0.0001% | $2.75 | $275 | +64.56% | |
| 2024-05-29 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 53,368 0.0761% | $2.55 | $136,110 | +29.92% | |
| 2024-05-22 | Sale | Delfini Lisa | Chief Financial Officer | 4,350 0.0062% | $2.64 | $11,485 | +20.94% | |
| 2024-05-20 | Sale | GOOD JENNIFER L | President & CEO | 25,037 0.0359% | $2.86 | $71,576 | +12.54% | |
| 2024-05-10 | Sale | GOOD JENNIFER L | President & CEO | 4,578 0.0069% | $2.90 | $13,276 | +16.12% | |
| 2023-10-11 | Sale | Delfini Lisa | Chief Financial Officer | 785 0.0012% | $2.02 | $1,586 | +32.11% | |
| 2023-09-11 | Sale | Delfini Lisa | Chief Financial Officer | 711 0.0011% | $2.20 | $1,564 | +15.27% |
| Heffernan Michael Thomas | director | 6351 0.0045% | $88,024.86 | 1 | 1 | <0.0001% |
| BASKETT FOREST | 10421428 7.3145% | $144.44M | 3 | 1 | +1.73% | |
| Makhzoumi Mohamad | 10421428 7.3145% | $144.44M | 3 | 1 | +1.73% | |
| NEA 16 GP, LLC | 10421428 7.3145% | $144.44M | 1 | 0 | <0.0001% | |
| SANDELL SCOTT D | 10 percent owner | 7789850 5.4675% | $107.97M | 2 | 1 | +10.22% |
| Walker Paul Edward | 10 percent owner | 7789850 5.4675% | $107.97M | 2 | 1 | +10.22% |
| Behbahani Ali | 10 percent owner | 7789850 5.4675% | $107.97M | 2 | 1 | +10.22% |
| New Enterprise Associates 16, L.P. | 10 percent owner | 7789850 5.4675% | $107.97M | 2 | 1 | +10.22% |
| Chang Carmen | 10 percent owner | 7789850 5.4675% | $107.97M | 2 | 1 | +10.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 10 percent owner | 6573000 4.6134% | $91.1M | 1 | 0 | <0.0001% |
| MAKOWER JOSHUA | 10 percent owner | 5937998 4.1677% | $82.3M | 1 | 1 | <0.0001% |
| BARRIS PETER J | 10 percent owner | 4438562 3.1153% | $61.52M | 1 | 0 | <0.0001% |
| MOTT DAVID M | 10 percent owner | 4438562 3.1153% | $61.52M | 1 | 0 | <0.0001% |
| Lundbeckfond Invest A/S | 10 percent owner | 1151544 0.8082% | $15.96M | 1 | 0 | <0.0001% |
| Agger Mette Kirstine | director | 1151544 0.8082% | $15.96M | 1 | 0 | <0.0001% |
| Omega Fund V, L.P. | 10 percent owner | 1063408 0.7464% | $14.74M | 1 | 0 | <0.0001% |
| Sonsini Peter W. | 948948 0.666% | $13.15M | 3 | 1 | +1.73% | |
| Florence Anthony A. Jr. | 948948 0.666% | $13.15M | 3 | 1 | +1.73% | |
| Meeker David P | director | 352489 0.2474% | $4.89M | 1 | 1 | <0.0001% |
| Richard King Mellon Foundation | 10 percent owner | 347157 0.2437% | $4.81M | 1 | 0 | <0.0001% |
| Mellon Family Investment Co V | 10 percent owner | 347156 0.2437% | $4.81M | 1 | 0 | <0.0001% |
| Aperture Venture Partners IV, L.P. | 10 percent owner | 344963 0.2421% | $4.78M | 1 | 0 | <0.0001% |
| GOOD JENNIFER L | President & CEO | 213313 0.1497% | $2.96M | 1 | 8 | <0.0001% |
| VANLENT ANNE | director | 25983 0.0182% | $360,124.38 | 1 | 0 | <0.0001% |
$607,395,062 | 99 | 4.23% | $1.88B | |
$21,345,882 | 83 | 94.45% | $2.19B | |
$47,419,530 | 58 | 17.20% | $1.96B | |
$1,376,668 | 53 | 18.46% | $2.1B | |
$108,353,116 | 49 | 15.41% | $2.17B |
| Increased Positions | 109 | +71.71% | 19M | +14.49% |
| Decreased Positions | 63 | -41.45% | 18M | -13.74% |
| New Positions | 34 | New | 6M | New |
| Sold Out Positions | 16 | Sold Out | 727,644 | Sold Out |
| Total Postitions | 198 | +30.26% | 130M | +0.75% |
| Nea Management Company, Llc | $157,212.00 | 10.33% | 13.22M | 0 | 0% | 2025-09-30 |
| Frazier Life Sciences Management, L.P. | $121,984.00 | 8.02% | 10.26M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $117,724.00 | 7.74% | 9.9M | +2M | +20.67% | 2025-09-30 |
| Rubric Capital Management Lp | $101,444.00 | 6.67% | 8.53M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $69,283.00 | 4.55% | 5.83M | +510,295 | +9.6% | 2025-09-30 |
| Viking Global Investors Lp | $60,982.00 | 4.01% | 5.13M | +4M | +232.4% | 2025-09-30 |
| Vivo Capital, Llc | $60,576.00 | 3.98% | 5.09M | +606,765 | +13.52% | 2025-09-30 |
| Marshall Wace, Llp | $57,568.00 | 3.78% | 4.84M | +2M | +95.4% | 2025-09-30 |
| Morgan Stanley | $51,148.00 | 3.36% | 4.3M | +3M | +320.09% | 2025-09-30 |
| Alliancebernstein L.P. | $51,037.00 | 3.35% | 4.29M | +11,096 | +0.26% | 2025-09-30 |